Evidence map›Paper›PMID 42509556›Full record

ArticleJournal of cheminformatics2026

Computational mapping of productive POI-E3 ligase conformations to guide de novo degrader design: application to WEE1 and PKMYT1 PROTACs.

Husam Nassar, Matthias Schmidt, Hany S Ibrahim, Dina Robaa, Wolfgang Sippl

Abstract read
In one paragraph

Article in Journal of cheminformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Husam NassarDepartment of Medicinal Chemistry, Institute of Pharmacy, Martin-Luther University Halle-Wittenberg, Halle (Saale), Germany.
Matthias SchmidtDepartment of Medicinal Chemistry, Institute of Pharmacy, Martin-Luther University Halle-Wittenberg, Halle (Saale), Germany.
Hany S IbrahimDepartment of Medicinal Chemistry, Institute of Pharmacy, Martin-Luther University Halle-Wittenberg, Halle (Saale), Germany.
Dina RobaaDepartment of Medicinal Chemistry, Institute of Pharmacy, Martin-Luther University Halle-Wittenberg, Halle (Saale), Germany.
Wolfgang SipplDepartment of Medicinal Chemistry, Institute of Pharmacy, Martin-Luther University Halle-Wittenberg, Halle (Saale), Germany. wolfgang.sippl@pharmazie.uni-halle.de.

Funding

Deutsche Forschungsgemeinschaft project number 468534282, 553776460 and 495271833
6 · The paper itself

Abstract

Targeted protein degradation has emerged as a promising therapeutic strategy, yet rational degrader design remains challenged by the dynamic nature of protein of interest (POI)-E3 ligase interactions. While X-ray crystallography and cryo-EM provide valuable structural snapshots, they are insufficient for capturing the conformational heterogeneity underpinning efficient ubiquitination and degradation. Here, we present a unified computational workflow to systematically generate and evaluate POI-E3 ligase conformational states for CRBN- and VHL-mediated proteolysis-targeting chimeras (PROTACs). The workflow integrates warhead connectivity analysis, conformational clustering, ubiquitination accessibility assessment and molecular dynamics simulations to identify productive POI-E3 ligase geometries. Analysis of experimental structures revealed that PROTAC linkers do not exceed 15 Å, providing a practical attachment-atom distance based filter for docking-derived models. Furthermore, POI-E3 ligase conformations differing by more than 7.5 Å Cα RMSD exhibited distinct ubiquitination profiles, offering quantitative guidance for defining structurally and functionally divergent states. Experimental ternary complexes consistently positioned one or more solvent-exposed POI lysine residues within 50 Å of the E2 catalytic Cys111, establishing a mechanistically grounded criterion for ubiquitination competence. Validation against 34 experimentally determined PROTAC ternary complexes achieved a 97% recovery rate and identified multiple ubiquitination competent conformations beyond experimental snapshots. The workflow was subsequently applied to model productive WEE1-CRBN and PKMYT1-CRBN conformations, for which no experimental structures are available. PROTAC induced-fit docking demonstrated that active PROTACs selectively engage productive POI-E3 ligase geometries with linker-compatible attachment atom distances. Overall, this study provides a quantitative, structure-based framework for guiding the rational design of ubiquitination-based degraders. The code and example data supporting this workflow are openly available at https://github.com/Husam-PSE/PROTACMap .Scientific contributionThis study offers a generalizable computational framework for identifying productive POI-E3 ligase conformations. It demonstrates that effective degradation depends on the interplay between conformational diversity, feasible warhead connectivity and preserved ubiquitination competence, rather than solely on ternary complex stability or binding affinity. Our computational approach was applied on WEE1 and PKMYT1 PROTACs for which no experimental ternary structure is available.

Indexed as

PKMYT1PROTACsTargeted protein degradationUbiquitinationWEE1

Identifiers

PMID42509556
PMCPMC13404913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.